137 related articles for article (PubMed ID: 24796777)
1. [Patient registries from the view of health policy].
Kissné Horváth I
Orv Hetil; 2014 May; 155(19):729-31. PubMed ID: 24796777
[TBL] [Abstract][Full Text] [Related]
2. Cancer registration, public health and the reform of the European data protection framework: Abandoning or improving European public health research?
Andersen MR; Storm HH;
Eur J Cancer; 2015 Jun; 51(9):1028-38. PubMed ID: 24120502
[TBL] [Abstract][Full Text] [Related]
3. Balancing the Optimal and the Feasible: A Practical Guide for Setting Up Patient Registries for the Collection of Real-World Data for Health Care Decision Making Based on Dutch Experiences.
de Groot S; van der Linden N; Franken MG; Blommestein HM; Leeneman B; van Rooijen E; Koos van der Hoeven JJ; Wouters MW; Westgeest HM; Uyl-de Groot CA
Value Health; 2017 Apr; 20(4):627-636. PubMed ID: 28408005
[TBL] [Abstract][Full Text] [Related]
4. The importance of effective registries in pulmonary diseases and how to optimize their output.
Chorostowska-Wynimko J; Wencker M; Horváth I
Chron Respir Dis; 2019; 16():1479973119881777. PubMed ID: 31645111
[TBL] [Abstract][Full Text] [Related]
5. EUROCOURSE lessons learned from and for population-based cancer registries in Europe and their programme owners: Improving performance by research programming for public health and clinical evaluation.
Coebergh JW; van den Hurk C; Rosso S; Comber H; Storm H; Zanetti R; Sacchetto L; Janssen-Heijnen M; Thong M; Siesling S; van den Eijnden-van Raaij J
Eur J Cancer; 2015 Jun; 51(9):997-1017. PubMed ID: 25956208
[TBL] [Abstract][Full Text] [Related]
6. Policies and actions to tackle rare diseases at European level.
Montserrat A; Taruscio D
Ann Ist Super Sanita; 2019; 55(3):296-304. PubMed ID: 31553326
[TBL] [Abstract][Full Text] [Related]
7. Patient registries: utility, validity and inference.
Richesson R; Vehik K
Adv Exp Med Biol; 2010; 686():87-104. PubMed ID: 20824441
[TBL] [Abstract][Full Text] [Related]
8. [Hungarian Hypertension Registry].
Kiss I; Kékes E
Orv Hetil; 2014 May; 155(19):764-8. PubMed ID: 24796784
[TBL] [Abstract][Full Text] [Related]
9. The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh.
Teerawattananon Y; Tantivess S; Yamabhai I; Tritasavit N; Walker DG; Cohen JT; Neumann PJ
Health Res Policy Syst; 2016 Dec; 14(1):86. PubMed ID: 27912780
[TBL] [Abstract][Full Text] [Related]
10. [Hungarian national plan and strategy for rare diseases].
Kosztolányi G
Orv Hetil; 2014 Mar; 155(9):325-8. PubMed ID: 24566695
[TBL] [Abstract][Full Text] [Related]
11. The national database of hospital-based cancer registries: a nationwide infrastructure to support evidence-based cancer care and cancer control policy in Japan.
Higashi T; Nakamura F; Shibata A; Emori Y; Nishimoto H
Jpn J Clin Oncol; 2014 Jan; 44(1):2-8. PubMed ID: 23448800
[TBL] [Abstract][Full Text] [Related]
12. RD-RAP: beyond rare disease patient registries, devising a comprehensive data and analytic framework.
Bellgard MI; Snelling T; McGree JM
Orphanet J Rare Dis; 2019 Jul; 14(1):176. PubMed ID: 31300021
[TBL] [Abstract][Full Text] [Related]
13. National Cancer Patient Registry--a patient registry/clinical database to evaluate the health outcomes of patients undergoing treatment for cancers in Malaysia.
Lim GC; Azura D
Med J Malaysia; 2008 Sep; 63 Suppl C():55-6. PubMed ID: 19230247
[TBL] [Abstract][Full Text] [Related]
14. A model for the European platform for rare disease registries.
Vittozzi L; Gainotti S; Mollo E; Donati C; Taruscio D
Public Health Genomics; 2013; 16(6):299-304. PubMed ID: 24503590
[TBL] [Abstract][Full Text] [Related]
15. Rare Disease Registries Are Key to Evidence-Based Personalized Medicine: Highlighting the European Experience.
Kölker S; Gleich F; Mütze U; Opladen T
Front Endocrinol (Lausanne); 2022; 13():832063. PubMed ID: 35317224
[TBL] [Abstract][Full Text] [Related]
16. Policies to foster quality improvement registries: lessons from the Swedish case.
Levay C
J Intern Med; 2016 Feb; 279(2):160-72. PubMed ID: 26435356
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for Improving the Quality of Rare Disease Registries.
Kodra Y; Weinbach J; Posada-de-la-Paz M; Coi A; Lemonnier SL; van Enckevort D; Roos M; Jacobsen A; Cornet R; Ahmed SF; Bros-Facer V; Popa V; Van Meel M; Renault D; von Gizycki R; Santoro M; Landais P; Torreri P; Carta C; Mascalzoni D; Gainotti S; Lopez E; Ambrosini A; Müller H; Reis R; Bianchi F; Rubinstein YR; Lochmüller H; Taruscio D
Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30081484
[TBL] [Abstract][Full Text] [Related]
18. The value of a European registry for pituitary adenomas: the example of Cushing's syndrome registry.
Webb SM; Santos A; Valassi E
Ann Endocrinol (Paris); 2012 Apr; 73(2):83-9. PubMed ID: 22541996
[TBL] [Abstract][Full Text] [Related]
19. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
20. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
